"We provide help and inspire hope to those affected by cancer through high quality, advanced oncology and hematology cancer treatments and leading-edge technology."

During the past decade, Northwest Georgia Oncology Centers PC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Georgia Oncology Centers PC" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Georgia Oncology Centers PC" are "Metastatic Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Prostate Cancer" (1 trials), "Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Northwest Georgia Oncology Centers PC" in a lesser frequency.

Most popular intervention types in "Northwest Georgia Oncology Centers PC" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Active Comparator (erlotinib)" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Georgia Oncology Centers PC" are 3 trials for "Female" genders, 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Georgia Oncology Centers PC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Northwest Georgia Oncology Centers PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Georgia Oncology Centers PC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".